Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.070 | 0.714 | 7 | 2009 | 2019 | ||||||
Malignant neoplasm of breast
|
3417 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.070 | 0.714 | 7 | 2009 | 2019 | ||||||
Polycystic Ovary Syndrome
|
363 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.050 | 0.600 | 5 | 2015 | 2019 | ||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.040 | 1.000 | 4 | 2012 | 2018 | ||||||
Osteoporosis
|
182 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.040 | 1.000 | 4 | 2014 | 2018 | ||||||
Obesity
|
1111 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||||
Tuberculosis
|
328 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.030 | 1.000 | 3 | 2016 | 2019 | ||||||
Asthma
|
1536 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2020 | 2020 | ||||||
Carcinoma, Ovarian Epithelial
|
327 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2007 | 2018 | ||||||
Coronary Artery Disease
|
1577 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2009 | 2019 | ||||||
Dermatitis, Atopic
|
232 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2016 | 2020 | ||||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 2 | 2013 | 2019 | |||||||
Eczema
|
368 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2016 | 2020 | ||||||
Graves Disease
|
352 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2005 | 2018 | ||||||
HIV-1 infection
|
94 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2008 | 2010 | ||||||
Kidney Calculi
|
71 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2016 | 2019 | ||||||
Lupus Erythematosus, Systemic
|
1172 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2017 | ||||||
Malignant neoplasm of prostate
|
1082 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 0.500 | 2 | 2017 | 2018 | ||||||
Metabolic Syndrome X
|
591 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 0.500 | 2 | 2018 | 2019 | ||||||
Neoplasms
|
1644 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2011 | 2016 | ||||||
Nephrolithiasis
|
99 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2016 | 2019 | ||||||
Osteoporosis, Postmenopausal
|
38 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||
Parkinson Disease
|
990 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2017 | 2019 | ||||||
Prostate carcinoma
|
1168 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 0.500 | 2 | 2017 | 2018 | ||||||
Tuberculosis, Pulmonary
|
171 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2017 | 2019 |